Adaptive Biotechnologies Corp
ADPT· Nasdaq
Released Nov 10, 2020, after the close
10-Q filed Nov 10, 2020, 41 days after period end · 0001564590-20-053007
| Metric | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|
| Revenue | $26.30M | $26.06M | $17.19M |
| Net Income | -$36.72M | -$13.95M | -$8.29M |
| EPS Diluted | -$0.27 | -$0.11 | -$0.66 |
Adaptive Biotechnologies Corp · CIK 1478320 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.